Life Scientist > Biotechnology

Mini kidneys bioprinted in the lab

01 December, 2020

The bioprinting method is faster and more reliable than previous methods, with the ability to create about 200 mini kidneys in 10 minutes without compromising quality.


Oxford COVID-19 vaccine meets primary efficacy endpoint

25 November, 2020

Interim Phase 3 trial data shows that the vaccine candidate AZD1222 is effective at preventing COVID-19 and offers a high level of protection.


Pfizer/BioNTech COVID-19 vaccine meets primary endpoints

20 November, 2020

Pfizer and BioNTech have completed the final efficacy analysis in the ongoing Phase 3 study of their mRNA-based COVID-19 vaccine candidate, BNT162b2.


High efficacy, long shelf life for Moderna's COVID-19 vaccine

18 November, 2020

Interim analysis of Moderna's Phase 3 study of mRNA-1273 finds that the COVID-19 vaccine candidate has an efficacy of 94.5% and remains stable at -20°C for up to six months.


Simple medical device helps to reverse alcohol intoxication

16 November, 2020

ClearMate allows a patient to hyperventilate off the alcohol in their system while returning precisely the amount of carbon dioxide to the body to keep it at normal levels in the blood.


Russia claims 92% efficacy for COVID-19 vaccine

13 November, 2020 by Lauren Davis

Hot on the heels of Pfizer and BioNTech's SARS-CoV-2 vaccine candidate, Russia's Sputnik V has demonstrated high efficacy of 92%.


Pfizer and BioNTech's COVID-19 vaccine shows 90% efficacy

10 November, 2020

Pfizer and BioNTech say their SARS-CoV-2 vaccine candidate has proved more than 90% effective in preventing COVID-19 in participants without prior evidence of infection.


Aus Govt secures two more COVID-19 vaccine agreements

06 November, 2020

The Australian Government has secured 50 million more doses of COVID-19 vaccines, as a result of new agreements with Novavax and Pfizer/BioNTech.


'Undruggable' oncogene inhibited in promising cancer trial

03 November, 2020

A novel agent that targets a mutated form of the KRAS gene — the most commonly altered oncogene in human cancers — shrank tumours in most patients in a clinical trial.


Steroid boosts survival of premmies in low-resource settings

02 November, 2020

Dexamethasone can boost survival of premature babies when given to pregnant women at risk of preterm birth in low-resource settings.


Anticancer candidate inhibits drug-induced hyperglycaemia

26 October, 2020

A new anticancer drug candidate offers a way to inhibit both tumour growth and drug-induced hyperglycaemia in multiple models of HR+ breast cancer.


Disappointing results for WHO's COVID-19 therapeutics trial

21 October, 2020 by Lauren Davis

Interim results indicate that the four treatments tested appear to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalised patients.


Single daily pill for Parkinson's disease developed

06 October, 2020

Scientists have developed a pill which uses the stomach as a drug reservoir and delivers medicines slowly over time to patients with Parkinson's disease.


Diabetes drug benefits cognition, pregnancy outcomes

29 September, 2020

Metformin could be particularly beneficial for people with type 2 diabetes who are older or looking to become pregnant, as discovered by two separate studies.


TGA approves gene therapy to treat retinal disease

25 September, 2020

The TGA has registered Novartis's LUXTURNA, the first gene therapy in Australia, for the treatment of patients with inherited retinal dystrophy.


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd